Amanote Research
Register
Sign In
The Adenosine A2A Receptor Agonist Accelerates Bone Healing and Adjusts Treg/Th17 Cell Balance Through Interleukin 6
BioMed Research International
- United States
doi 10.1155/2020/2603873
Full Text
Open PDF
Abstract
Available in
full text
Categories
Immunology
Molecular Biology
Biochemistry
Microbiology
Medicine
Genetics
Date
April 23, 2020
Authors
Xi Zheng
Dong Wang
Publisher
Hindawi Limited
Related search
The Balance Between Treg and TH17cells: CD11b and Interleukin-6
European Journal of Immunology
Allergy
Immunology
Free Energy Calculations of A2A Adenosine Receptor Mutation Effects on Agonist Binding
Chemical Communications
Surfaces
Alloys
Materials Chemistry
Coatings
Metals
Optical
Magnetic Materials
Films
Catalysis
Chemistry
Electronic
Composites
Ceramics
CD11b Regulates the Treg/Th17 Balance in Murine Arthritis via IL-6
European Journal of Immunology
Allergy
Immunology
Mesenchymal Stem Cells Regulate the Th17/Treg Cell Balance Partly Through Hepatocyte Growth Factor in Vitro
Stem Cell Research and Therapy
Genetics
Cell Biology
Molecular Biology
Biochemistry
Medicine
Molecular Medicine
Editorial: Regadenoson: An Adenosine A2A Receptor Agonist for Pharmacological Myocardial Perfusion Imaging
Journal of Cardiology Cases
Cardiovascular Medicine
Cardiology
The Adenosine Metabolite Inosine Is a Functional Agonist of the Adenosine A2A Receptor With a Unique Signaling Bias
Cellular Signalling
Cell Biology
Adenosine Through the A2A Adenosine Receptor Increases IL-1β in the Brain Contributing to Anxiety
Brain, Behavior, and Immunity
Endocrine
Immunology
Behavioral Neuroscience
Autonomic Systems
Metformin Attenuates Experimental Autoimmune Arthritis Through Reciprocal Regulation of Th17/Treg Balance and Osteoclastogenesis
Mediators of Inflammation
Immunology
Cell Biology
An A2B Adenosine Receptor Agonist Promotes Th17 Autoimmune Responses in Experimental Autoimmune Uveitis (EAU) via Dendritic Cell Activation
PLoS ONE
Multidisciplinary
